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The Virtues of Oxygenation: Low
Tissue Oxygen Adversely Affects the
Killing of Leishmania
Lopa M. Das1 and Kurt Q. Lu1
Hypoxia contributes to the persistence of infections through altered immune
responses. Studies examining skin O2 changes at the site of a lesion are limited.
The prevailing methods require the use of electrochemical O2 sensors or
radiolabeled electrodes that utilize O2 and may interfere with the precision at
low O2 levels. In this issue, Mahnke et al. (2014) demonstrate, using a novel
fluorescence-based imaging technology, that low oxygen tension (pO2) impairs
NO-mediated anti-leishmanial immunity, leading to increased parasite burden.
Replenishing tissue oxygen profoundly enhanced NO-mediated leishmanial kill-
ing, underscoring the need to accurately assess oxygenation in infected tissues as
a novel strategy to challenge intracellular infection. The technology presented
here may have clinical-translational potential in noninvasively assessing disease
burden and response to treatment.
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Hypoxia in medicine, inflammation, and
infection
O2 therapy is emerging as one of the
most effective yet inexpensive forms of
alternative medicine for several patho-
logical states. This notion evolves from
studies demonstrating that improved
tissue oxygenation combined with anti-
microbials has achieved greater efficacy
in pathogen clearance (Knighton et al.,
1986). During infection and disease, O2
demand can increase because of various
factors including increased metabolism of
infiltrated immune cells and microbial
proliferation, resulting in a hypoxic envi-
ronment (Lewis et al., 1999). Hypoxia has
a pleiotropic role in tissue inflammation
and infection and may exacerbate or atte-
nuate disease. Depending on the patho-
gen, low pO2 can evoke heightened
antimicrobial innate immune responses
or, conversely, support pathogen adap-
tation, proliferation, and survival, result-
ing in propagation of infection (Degrossoli
et al., 2011; Sen Santara et al., 2013).
Areas of inadequate O2 tension in the
lung of cystic fibrosis patients support
colonization of Pseudomonas bacteria to
establish infection and effectively block
host immune responses (Callaghan and
McClean, 2012). Eukaryotic organisms,
including Leishmania parasites, express a
heme containing globin protein that
functions as a natural O2 sensor to
detect hypoxia and adapt accordingly
to prevent cell death (Sen Santara et al.,
2013). These and other protozoan, bac-
terial, and viral infections are modulated
by hypoxia, either directly or through
the activation of other antimicrobial
responses such as defensins.
Effect of hypoxia on NO-dependent
regulation of Leishmania infection
Leishmania are intracellular protozoan
parasites that reside within professional
antigen-presenting cells (macrophages
and dendritic cells (DCs)) to cause
cutaneous leishmaniasis, characterized
by skin lesions and intracellular parasite
load. Although significant advances in
drug therapy have allowed for control of
intracellular proliferation of Leishmania,
the drugs in use have severe side effects,
urging alternative strategies to be consi-
dered. Potentiating a robust host
immune response through macrophage-
mediated NO production may permit
a lower dose of drug administration
and thus a more effective combinatorial
approach to reduce parasite burden. In
this issue, Mahnke et al. (2014) present an
elegant study demonstrating a critical role
for transcutaneous O2 in modulating the
course of infection in a murine model
of cutaneous leishmaniasis. Host immune
responses to Leishmania include macro-
phage infiltration, activation, phago-
cytosis, and NO-mediated killing. Using
a self-resolving model of cutaneous
leishmaniasis to study the effect of
pO2 on immune response, the authors
demonstrate that low O2 tension in
leishmanial skin lesions renders mice
susceptible to infection due to insufficient
O2-dependent NO production. This
model allowed them to delineate using
NOS2 / mice that NO-driven anti-
leishmanial activity is fundamentally
linked to tissue O2 levels and can be inhi-
bited in spite of normal NOS2 expression.
The Mahnke findings may be strain-
specific as two separate in vitro studies
of Leishmania-parasitized macrophages
demonstrate that activated macrophages
under hypoxic conditions are less sus-
ceptible to L. amazonensis infection
(Colhone et al., 2004) and that hypoxia
renders infected macrophages unres-
ponsive to anti-leishmanial drugs
(Ayres et al., 2008). In addition, macro-
phages show enhanced infiltration and
increased microbicidal activity (through
the expression of mediators such as
hypoxia-inducible factor-1a (HIF-1a))
under hypoxic conditions, suggesting
that macrophages are most adaptable
to a hypoxic microenvironment.
The study reported by Mahnke builds
on earlier studies demonstrating that
hypoxia enhanced cytokine and Toll-
like receptor (TLR) ligand–induced mRNA
and protein expression of NOS2 in
macrophages, yet it inhibited NO pro-
duction (Albina et al., 1995; Melillo
et al., 1996), partially because of an
impaired mitochondrial respiratory
chain (Wiese et al., 2012). A study by
Daniliuc et al. (2003) elucidates the
mechanism, demonstrating that low
pO2 causes prolonged inactivation of
the NOS2 protein by disrupting its inter-
1Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA
Correspondence: Lopa M. Das, Case Western Reserve University, 2109 Adelbert Road, BRB 529,
Cleveland, Ohio 44106, USA. E-mail: lxd30@case.edu
COMMENTARY
www.jidonline.org 2303
action with the cytoskeleton. Together,
these results emphasize the profound
influence of hypoxia on anti-leish-
manial activity, especially in macro-
phages, and supports the concept that
hypoxia induces NOS2 protein but
impairs NO production.
Importantly, in recent studies the
same authors have demonstrated that
TLR ligation of DCs under hypoxia
induces and stabilizes HIF-1a, a
molecule required for adaptation and
induction of an inflammatory response
(Jantsch et al., 2011). This is important
because NO production in the PC-12
cell line varies inversely with HIF-1a
expression and function (Agani et al.,
2002). The fact that NO-mediated
leishmanial killing is compromised by
hypoxia as demonstrated by Mahnke
et al. (2014) in this issue can be rationa-
lized by increased HIF-1a induction that
favored parasite survival (Singh et al.,
2012).
Hypoxia modulation of NO-independent
pathways of macrophage infection and
parasite survival
Studies indicate that hypoxia at the site
of leishmanial infection causes macro-
phage infiltration and bolsters immune
activation to modulate leishmanial kill-
ing via NO-independent mechanisms.
In a mouse model of L. amazonensis
infection, low O2 tension improves
macrophage control of Leishmania
infection through expression of HIF-1a.
The fact that poor O2 levels in skin
lesions enhance adhesion and extra-
vasation of macrophages to the endo-
thelium and subsequent infiltration into
tissues (Dietz et al., 2012) supports
the notion that macrophages are the
predominant cells to phagocytose and
eliminate Leishmania. However, certain
strains of Leishmania utilize HIF-1a
to their advantage so that it serves as
a survival factor for parasitized macro-
phages, and inhibition of HIF-1a
reduces parasite survival. The critical
role of hypoxia in parasite survival
is in agreement with work by Sen
Santara et al. (2013) demonstrating that
hypoxia compromises Leishmania and
Trypanosoma promastigote survival by
impairment of an O2-dependent cAMP
signaling pathway via protein kinase A.
These studies unify the theme that lack
of adequate tissue oxygenation at the
site of infection or infected lesion mobi-
lizes the expression of critical factors
and modulates several pathways that
interfere with the establishment of
infection and parasite survival.
Assessment of transcutaneous pO2 and its
effect on infection
Measurement of transcutaneous O2 at
the site of infection is a popular method
of evaluating microbial persistence or
its clearance. In the study by Mahnke
et al. (2014), the authors measure trans-
cutaneous O2 levels using planar sensor
films to obtain luminescence-2D-in vivo
oxygen imaging. Other strategies to
quantify skin O2 levels include hyper-
spectral imaging that allows for evalua-
tion and visualization of acute changes
in oxygenation and perfusion in skin
following irradiation (Chin et al.,
2012). Their study reveals that parasite
load is maximized at a point in time
when skin pO2 has reached its nadir.
Selecting a self-resolving mouse model
of cutaneous leishmaniasis allowed
Mahnke et al. (2014) to monitor trans-
cutaneous O2 from maximum parasite
burden to the time until infection has
cleared. pO2 ranged from acute hypoxia
to normoxia, and NO production reflec-
ted a similar pattern. The model also
allowed the authors to explore further
whether the resolving phenotype,
corresponding to normoxia, could be
altered by modulating pO2 at the site
of infection. Through gain and loss of
function approaches, Mahnke et al.
(2014) establish that NO-mediated
L. major killing depends on an ade-
quate supply of tissue O2. To advance
our understanding that accurate assess-
ment of pO2 tension can predict the
status of an immune response against
L. major infection in an NO-dependent
manner, the authors methodically elimi-
nate the possibilities that reduced NO
level is a result of impaired protein syn-
thesis, or insufficient iNOS substrate
arginine, and establish that reduced
NO production is a direct conse-
quence of inadequate skin O2 levels.
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A New Player on the Psoriasis Block:
IL-17A- and IL-22-Producing Innate
Lymphoid Cells
Nicole L. Ward1 and Dale T. Umetsu2
Innate lymphoid cells (ILCs) are a recently discovered family of innate immune
cells belonging to the lymphoid lineage, yet lacking antigen-specific receptors.
ILCs were first identified in the intestinal tract, where they contribute to epithelial
barrier integrity and host responses to commensal microbes. Teunissen et al. (in
the current issue) and Villanova et al. (2014) now suggest an important role for
type 3 ILCs (ILC3s) in the skin, particularly in psoriasis. Both groups found an
increased frequency of IL-22- and/or IL-17A-producing ILCs in psoriatic skin and
blood. These cells are activated in response to IL-1b and IL-23, correlate with
disease severity, and are decreased following antitumor necrosis factor-a (anti-
TNFa) treatment. The presence of a novel ILC population in psoriatic skin, one
that responds to biologic therapeutics, suggests that dysregulation of ILCs is a
contributing factor to psoriasis pathogenesis.
Journal of Investigative Dermatology (2014) 134, 2305–2307. doi:10.1038/jid.2014.216
Innate lymphoid cells (ILCs) represent a
family of multifunctional, lymphoid-
lineage cells that lack B- and T-cell
receptors and display innate immune
effector functions. These cells often
reside at mucosal interfaces where they
rapidly produce cytokines in response to
environmental challenges. At least three
groups of ILCs have been identified,
based upon unique transcription factor
utilization, cytokine profiles, and effec-
tor functions. Groups 1 and 2 produce
type 1 and 2 cytokines, respectively,
whereas group 3 has a unique capacity
to produce IL-17A and IL-22. Dysregu-
lation of ILCs has been implicated in
autoimmune and inflammatory diseases,
thus broadening our understanding of
how innate immune cells contribute to
disease pathogenesis.
However, less well understood
until now is the potential role of ILCs
in psoriasis. Two papers, both published
in the Journal of Investigative Dermato-
logy in 2014 (Teunissen et al., 2014;
Villanova et al., 2014), provide com-
pelling evidence for a pathogenic role of
ILCs in psoriasis. Teunissen et al. (2014)
show the upregulation of group 3 ILCs
(ILC3s) in nonlesional and lesional
skin and in blood of psoriasis patients,
and that these cells are novel cellular
sources of IL-22 in the skin. Nestle
and colleagues (Villanova et al., 2014)
demonstrate a close association bet-
ween disease improvement and the
number of IL-17A- and IL-22-producing
ILC3s in the skin and in circulation
following antitumor necrosis factor-a
(anti-TNFa) therapy, suggesting that
ILC3s contribute to the pathogenesis of
psoriasis.
ILCs
ILCs lack T-cell receptors and B-cell
receptors, and therefore are antigen non-
specific; however, they respond rapidly
to environmental challenges, such as
tissue injury or infection, via cytokine
secretion. Type 1 ILCs, or ILC1s, require
the transcription factor T-bet, are
induced in response to IL-12, produce
type 1 cytokines such as IFNg, and have
been observed in the intestines of
patients with inflammatory bowel dis-
ease. Type 2 ILCs, or ILC2s, require the
transcription factor RORa and GATA3,
respond to the innate cytokines IL-33, IL-
25, and thymic stromal lymphopoietin
(TSLP), produce IL-5 and IL-13 but not
IL-4, and have been found in the intes-
tines in the context of helminth infection
(Neill et al., 2010), in the lungs in the
context of asthma (Chang et al., 2011),
and in the skin in the context of atopic
dermatitis (Salimi et al., 2013). Type 3
ILCs, or ILC3s, require the transcription
factor RORgt, respond to IL-23 and IL-
1b, and produce IL-17A and/or IL-22.
ILC3s producing IL-17A have been
observed in the intestines of patients
with Crohn’s disease (Coccia et al.,
2012) and in the lungs of patients with
nonallergic asthma (Kim et al., 2014).
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